FDA approves Johnson & Johnson’s TREMFYA for ulcerative colitis
Johnson & Johnson has announced that the US FDA has approved TREMFYA for the treatment of active ulcerative colitis (UC).
Johnson & Johnson has announced that the US FDA has approved TREMFYA for the treatment of active ulcerative colitis (UC).
What's Your Reaction?
